カワカミ エミコ
Kawakami Emiko
川上 恵美子 所属 医学部 医学科(東京女子医科大学病院) 職種 助手 |
|
言語種別 | 英語 |
発表タイトル | Blood Urea Nitrogen to Albumin Ratio Predicts Mortality of Heart Failure Patients with Cardiac Resynchronization Therapy |
会議名 | The 81st Annual Scientific Meeting of the Japanese Circulation Society (JCS2017) |
主催者 | Japanese Circulation Society |
学会区分 | 全国規模の学会 |
発表形式 | ポスター掲示 |
講演区分 | 一般 |
発表者・共同発表者 | ◎KAWAKAMI Emiko, SUZUKI Atsushi, SHIGA Tsuyoshi, IWANAMI Yuji, HENMI Ryuta, YAGISHITA Daigo, EJIMA Koichiro, SUZUKI Tsuyoshi, SHODA Morio, HAGIWARA Nobuhisa |
発表年月日 | 2017/03/19 |
開催地 (都市, 国名) |
Kanazawa, JAPAN |
学会抄録 | PROGRAM JCS 2017 389 |
概要 | Serum albumin and renal function play an important role in maintaining physiological homeostasis. The aim of this study is to evaluate the association between blood urea nitrogen to albumin (B/A) ratio before cardiac resynchronization therapy (CRT) implantation and mortality. We studied 391 patients who implanted CRT between 2002 to 2014. During 32 months of follow-up, 117 (30%) patients died from any cause. There was a significantly higher B/A ratio in dead patients than survived (p<0.05). 63% of CRT patients had decreased left ventricular end-systolic volume (LVESV) more than 15% after 6 months of CRT (responders). By cox regression analysis, independent risks for mortality were non-responder and high value of B/A ratio (Table). Our results suggested that B/A ratio is an independent predictor of mortality in HF patients treated by CRT. |